Research Tracker›Biomarker Atlas›Marker Pages›PBMC cytokine profile (PTLDS)

PBMC cytokine profile (PTLDS): biomarker evidence

PBMC cytokine profile (PTLDS) appears in 1 entry of the OSMF biomarker atlas, covering Lyme Disease. Across those entries it is mixed in 1. It is currently reported in a single condition in this atlas; cross-condition comparison will be added as the dataset grows. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

Lyme Disease

Where PBMC cytokine profile (PTLDS) is reported

Also listed as: Peripheral immune signature

ConditionDirectionCompared againstAssociated symptomsSource
Lyme Disease↕ inconsistenthealthy controls, recovered LymePost-treatment persistent symptomsAucott et al. 2014

Frequently asked questions

In which conditions is PBMC cytokine profile (PTLDS) altered?

In the OSMF atlas PBMC cytokine profile (PTLDS) is reported in Lyme Disease. It is mixed in 1 across 1 entries.

Is there a standard clinical test for PBMC cytokine profile (PTLDS)?

The atlas entries for PBMC cytokine profile (PTLDS) do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.

Is one abnormal PBMC cytokine profile (PTLDS) result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). PBMC cytokine profile (PTLDS) across conditions: biomarker evidence. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/markers/pbmc-cytokine-profile-ptlds.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.